Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03212404 |
|---|---|
| Brief Title: | Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers |
| First Submitted : | July 6, 2017 |
| First Submitted that Met QC Criteria : | July 6, 2017 |
| First Posted : | July 11, 2017 |
| Last Update Submitted that Met QC Criteria : | November 12, 2020 |
| Last Update Posted : | November 13, 2020 |